What is Novo Nordisk A/S's Shariah compliance score?

Novo Nordisk A/S (NVO) has a Shariah compliance score of 89/100 (Grade: A, Very Good) based on AAOIFI screening standards. Scores above 70 typically indicate strong compliance. The score factors in business activity screening and financial ratio analysis including debt levels, interest-bearing deposits, and prohibited income percentages. View the full breakdown at HalalScreener.app.

Does Novo Nordisk A/S pass AAOIFI screening?

Novo Nordisk A/S (NVO) passes AAOIFI Shariah screening. AAOIFI requires: (1) no primary involvement in prohibited activities like alcohol, gambling, or conventional banking, (2) debt-to-market-cap below 30% (NVO: 9.2%), (3) interest-bearing deposits below 30% (NVO: 1.9%), and (4) prohibited income below 5% (NVO: 0.4%). HalalScreener provides free AAOIFI screening for 10,000+ stocks at halalscreener.app.

How much purification is needed for Novo Nordisk A/S stock?

Novo Nordisk A/S (NVO) has a non-permissible income ratio of 0.41%. Muslim investors should purify this percentage of any dividends received and capital gains realized from NVO shares by donating it to charity. HalalScreener's purification calculator at halalscreener.app/en/purification automates this calculation using the latest financial data.

Where can I screen Novo Nordisk A/S for Shariah compliance for free?

HalalScreener (halalscreener.app) offers free Shariah compliance screening for Novo Nordisk A/S (NVO) and 10,000+ other US-listed stocks, ETFs, and 100+ cryptocurrencies. The screening uses AAOIFI Standard No. 21 and shows all financial ratios transparently. No credit card or signup required for basic screening. HalalScreener also includes an AI Islamic Scholar for follow-up questions about NVO's compliance across different madhabs (Hanafi, Shafi'i, Maliki, Hanbali, Ja'fari).

NVO: Is Novo Nordisk A/S Halal?

Novo Nordisk A/S

NYSEHealthcareDK

$49.07

-0.43%

Market Cap: 218.1B

Compliance Status

Halal

Screened on Jul 15, 2026 · AAOIFI Standard 21

Very Good

89Score

Is Novo Nordisk A/S (NVO) halal? Halal. Based on AAOIFI screening, Novo Nordisk A/S passes both qualitative (business activity) and quantitative (financial ratio) screens with a compliance score of 89/100 (Grade: A).

AvoidBorderlineClean

Business activity

What the company sells is permissible.

Passed

Company debt

Well clear of the limit

How much the company borrows, compared to its total value. AAOIFI allows up to 30%.

9.2% of 30.0% limit

What this means for you

You can own NVO

It passes both the business activity and financial ratio screens under AAOIFI Standard 21.

Purify 0.4% of your income from NVO

That is about $0.40 of every $100 you earn from it. Donate this share to charity.

Calculate my exact amount

About Novo Nordisk A/S

Novo Nordisk A/S is a global pharmaceutical firm dedicated to the investigation, creation, manufacturing, and distribution of medicinal products across a vast international footprint. Its market presence extends throughout Europe, the Middle East, Africa, various parts of Asia (including Mainland China, Hong Kong, and Taiwan), and North America. The company's operations are structured into two principal business units: Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity Care division delivers therapies for diabetes, obesity, cardiovascular ailments, and other emerging therapeutic areas. Meanwhile, the Rare Disease division concentrates on providing treatments for rare blood disorders, uncommon endocrine conditions, and hormone replacement solutions. In addition to its core pharmaceutical offerings, Novo Nordisk produces specialized medical equipment such as insulin pens, growth hormone pens, and injection needles. It also pioneers smart digital solutions for diabetes management, including advanced insulin pens and the Dose Check application, designed to guide insulin dosage. The company engages in strategic alliances, notably a partnership with UNICEF to combat childhood obesity and a collaboration with Valo Health, Inc. to discover and advance novel drug pipelines in the cardiometabolic space. Founded in 1923, Novo Nordisk A/S is headquartered in Bagsvaerd, Denmark.

Sector: Healthcare · Industry: Drug Manufacturers - General

Read Full Analysis

Is Novo Nordisk (NVO) Stock Halal? Shariah Compliance Analysis

Shariah Compliance Status

AAOIFI Standard 21Updated Jul 15, 2026

Compliance History

Halalnow
since Jun 2026
Not Halal
until the change above

Tracked since May 2026. Updates automatically on each re-screen.

Fiscal: FY 2025Data source: FMP-ADR

More Healthcare Stocks

JNJ

Johnson & Johnson

UNH

UnitedHealth Group Incorporated

B+

ABBV

AbbVie Inc.

PFE

Pfizer Inc.

LLY

Eli Lilly and Company

A+

MRK

Merck & Co., Inc.

B+

Free · No credit card required

Track NVO and 10,000+ stocks with AI insights

Create your free account to unlock AI-powered compliance analysis, track your portfolio, calculate purification, and get unlimited AAOIFI screening.

Get Started Free Browse Screener

10,000+ assets AAOIFI standards Free watchlist

Frequently Asked Questions

Is Novo Nordisk A/S (NVO) halal to invest in?

Based on AAOIFI Standard 21 screening, Novo Nordisk A/S (NVO) is rated Halal with a compliance grade of A (Very Good). It passes both the business activity screen (no primary involvement in prohibited sectors) and the quantitative financial ratio screen (debt, interest deposits, and prohibited income all below AAOIFI thresholds).

Why did Novo Nordisk A/S get a A compliance rating?

Novo Nordisk A/S (NVO) received a grade of A (Very Good) based on three AAOIFI Standard 21 financial ratios: debt-to-market-cap of 9.2% (limit 30%); interest-bearing deposits of 1.9% (limit 30%); prohibited income of 0.41% (limit 5%). The grade reflects the margin of safety across all three ratios relative to their thresholds.

What could change Novo Nordisk A/S's Shariah verdict?

Novo Nordisk A/S's verdict is re-evaluated at each annual re-screen. Three events could change it: (1) the debt-to-market-cap ratio crossing 30%, typically from new debt issuance or a major drop in share price; (2) interest-bearing deposits exceeding 30% of market cap; or (3) prohibited revenue (alcohol, gambling, conventional finance, etc.) exceeding 5% of total revenue. Verdict flips are tracked in the compliance history section above.

How often is Novo Nordisk A/S re-screened for Shariah compliance?

Novo Nordisk A/S (NVO) is re-screened annually using the most recent full-year financial data from SEC filings. HalalScreener also triggers an on-demand re-screen whenever the stored data is more than 7 days old, ensuring the ratios reflect the latest available financial statements. Last screened: Jul 15, 2026.

Screened according to AAOIFI Standard No. 21 · For informational purposes only. Consult a qualified Islamic finance advisor before investing.

Disclaimer: This screening is for informational purposes only and does not constitute financial, legal, or religious advice. Compliance is evaluated using AAOIFI financial standards (debt, deposits, and prohibited income ratios) and publicly available data. Ethical, political, social, or environmental considerations are outside the scope of this screening. Individual scholars and methodologies may differ. Always consult a qualified Islamic finance advisor before making investment decisions.